Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Nvidia Trounces AMD Once Again: Here's Why That's Great News for Nvidia ShareholdersPhoto, wide shot, wide-angle lens,  Networking equipment supplier, sunset photo at golden hour, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/66e3509e-f4c6-4a7b-8e88-53fcc02cf17f.png
Nvidia Trounces AMD Once Again: Here's Why That's Great News for Nvidia Shareholders

Shares of Nvidia (NASDAQ: NVDA) have nearly quadrupled in price since the beginning of 2020 thanks to the robust demand for its powerful graphics cards that power a variety of applications

Breaking Down Square's Balance Sheet
Breaking Down Square's Balance Sheet

Knowing how to read a balance sheet is an essential tool for all stock investors to have, and that's especially true when it comes to rapidly growing companies like Square (NYSE: SQ). In this Motley

Why Synopsys Stock Gained 15% in August
Why Synopsys Stock Gained 15% in August

Synopsys (NASDAQ: SNPS) shareholders beat a rallying market last month. The stock rose 15% in August compared to 3% spike in the S&P 500, according to data provided by S&P Global Market Intelligence

3 Recession-Ready Stocks to Buy in September
3 Recession-Ready Stocks to Buy in September

While the economy seems to be performing well as we recover from the COVID-19 pandemic, there is always the possibility that the country hits another recession. The most likely catalyst for another

Why Vertex Is Expanding a Gene-Editing Partnership -- and It's not With CRISPR TherapeuticsPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Why Vertex Is Expanding a Gene-Editing Partnership -- and It's not With CRISPR Therapeutics

Vertex Pharmaceuticals (NASDAQ: VRTX) has worked closely with CRISPR Therapeutics (NASDAQ: CRSP) for quite a while to develop a CRISPR gene-editing therapy targeting rare blood diseases. Recently

If You Invested $1,000 in Plug Power at Its IPO, This Is How Much You Would Have Today
If You Invested $1,000 in Plug Power at Its IPO, This Is How Much You Would Have Today

Although Plug Power (NASDAQ: PLUG) has been developing hydrogen fuel cells for almost a quarter of a century, its potential has yet to be fully realized. Its investors continue to wait for the

Important Stock Market Stories You Might Have Missed In AugustPhoto, wide shot, wide-angle lens,  Hedge fund, neutral atmosphere, photo by Charlie Waite: https://img.theapi.app/temp/95282efd-f725-49c0-be40-aa74627f7ccc.png
Important Stock Market Stories You Might Have Missed In August

August is usually a pretty calm month in the stock market, but it was eventful this year. We saw major news from the Federal Reserve, investors started to digest the impacts of a new wave of

AstraZeneca Enters Another Major Market With This Indication
AstraZeneca Enters Another Major Market With This Indication

Late last month, Japan's Ministry of Health, Labour, and Welfare (MHLW) approved AstraZeneca's (NASDAQ: AZN) diabetes and heart failure drug, Forxiga (known as Farxiga in the United States), to

Here's Why This Real Estate Disruptor Chose a SPAC to Go Public
Here's Why This Real Estate Disruptor Chose a SPAC to Go Public

The SPAC boom we saw in late 2020 and early 2021 may have cooled off a bit, but there are still some high-potential companies choosing the SPAC route to go public. One particularly interesting

How Ethereum's Next Big Upgrade Could Boost Its Value
How Ethereum's Next Big Upgrade Could Boost Its Value

Ethereum (CRYPTO: ETH)- the world's second-largest cryptocurrency, and the most popular smart contract and decentralized application network -- just changed the way it pays the people who maintain

Is Veeva Systems Stock a Buy?Photo, wide shot, wide-angle lens,  Cloud computing provider, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/893880f6-c6d9-4518-b1a0-f0be05207ac4.png
Is Veeva Systems Stock a Buy?

Veeva Systems' (NYSE: VEEV) stock price fell 5% following the release of the company's second-quarter earnings report on Sept. 1, even though the cloud-based services company beat analysts'

Digital Turbine Is Up 4,500% in the Last 3 Years -- Can You Still Buy?
Digital Turbine Is Up 4,500% in the Last 3 Years -- Can You Still Buy?

At the onset of the pandemic, Motley Fool contributors Brian Feroldi and Brian Stoffel ran a company called Digital Turbine (NASDAQ: APPS) through their respective frameworks. It didn't do well.

Space Is Hard, but These 3 Space Stocks Can Reach Orbit
Space Is Hard, but These 3 Space Stocks Can Reach Orbit

Shareholders of Astra Space (NASDAQ: ASTR) got a reminder last week that space is hard

The company, which went public earlier this year via a merger with a special purpose acquisition company, or 

Are COVID Vaccine Mandates Justified Based on the Data?: https://investors.biontech.de/media-materials
Are COVID Vaccine Mandates Justified Based on the Data?

COVID-19 vaccine mandates are controversial. But since the Food and Drug Administration fully approved the COVID vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX), more

Stop Guessing: Here's Exactly How to Retire a Millionaire
Stop Guessing: Here's Exactly How to Retire a Millionaire

A million-dollar nest egg can provide the financial security you deserve in retirement. But, for most people, it will take discipline and hard work to ensure your account balance is seven figures by

At Less Than $50, Could Pfizer Reach $100 Before 2025?Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
At Less Than $50, Could Pfizer Reach $100 Before 2025?

Pfizer (NYSE: PFE) is one of the world's leading pharmaceutical companies, and as you may have heard, it makes one of the most widely distributed coronavirus vaccines. Right now, its stock price is

Why This Ultra-High-Growth Healthcare Stock Is a BuyPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Why This Ultra-High-Growth Healthcare Stock Is a Buy

Investors love the explosive growth that many healthcare stocks can provide. But it's hard to find many that offer growth and profits like Progyny (NASDAQ: PGNY) does. In this video from Motley Fool

This Growth Stock Could Be 10 Times Larger in 10 Years
This Growth Stock Could Be 10 Times Larger in 10 Years

Shake Shack (NYSE: SHAK) started as a New York hot dog stand in Madison Square Park. It was the brainchild of Danny Meyer, best known as the restaurateur and CEO of Union Square Hospitality Group

3 Millionaire Retirement Strategies That Don't Rely on Social Security
3 Millionaire Retirement Strategies That Don't Rely on Social Security

Social Security is one of the most entrenched government programs in modern life, and you will get benefits from it in retirement. But the average benefit is just $1,543 per month and even the

4 Market-Topping Dividend Stocks That Can Double Your Money by 2026
4 Market-Topping Dividend Stocks That Can Double Your Money by 2026

There are a number of ways for investors to make money on Wall Street. However, dividend stocks stand head and shoulders above their peers.

In 2013, J.P. Morgan Asset Management released a report

Here's How to Make Even More Money From Your Side Hustle
Here's How to Make Even More Money From Your Side Hustle

A typical side hustle can bring in over $500 per month, according to The Ascent. It's a nice chunk of change, but it's not the fortune many envision when they begin their new venture. It might seem

Why Investors Should Love Pfizer's Acquisition of Trillium
Why Investors Should Love Pfizer's Acquisition of Trillium

Pfizer (NYSE: PFE) announced in August that it plans to acquire Trillium Therapeutics (NASDAQ: TRIL) for nearly $2.3 billion. In this Motley Fool Live video recorded on Aug. 25, Motley Fool

3 Stocks to Buy Hand Over Fist if There's a Stock Market Crash
3 Stocks to Buy Hand Over Fist if There's a Stock Market Crash

For investors, things just about couldn't be better. The benchmark S&P 500 (SNPINDEX: ^GSPC) has more than doubled since hitting its coronavirus pandemic low on March 23, 2020, and it's, thus far

Finish 2021 Strong With These 3 Investing MovesPhoto, wide shot, wide-angle lens,  Retail store, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/add1012b-1b24-4eb2-aba0-77ab52c7f8ad.png
Finish 2021 Strong With These 3 Investing Moves

Labor Day weekend marks the unofficial end of the summer season. For many of us, that means the end of travel, the return of school-related routines, and something of a brief lull before the

Delaying Social Security Could Backfire on You in These Scenarios
Delaying Social Security Could Backfire on You in These Scenarios

You'll often hear that it's a good idea to delay your Social Security filing until the age of 70. Though you're allowed to sign up for benefits as early as age 62, you're not entitled to your full